Skip to content

G-FLEX FLEXIBLE INSTRUMENTS EUROPE: what changed

BE 0876.308.490NACE 46.460, Wholesale of pharmaceutical and medical goodsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€637,051
2024 · €775,067-€138,016
Equity
€2.5m
2024 · €1.8m+€637,051
Cash
€830,520
2024 · €1.0m-€215,733
Balance sheet total
€3.7m
2024 · €3.2m+€519,435

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€682,498

    up €682,498 (+66.9%), from €1.0m to €1.7m

    of which Trade receivables: +€694,918

  • Cash -€215,733

    down €215,733 (-20.6%), from €1.0m to €830,520

    mainly Receivables within one year (-€682,498) and Advances received (-€133,023)

  • Stocks and contracts +€96,846

    up €96,846 (+10.1%), from €963,106 to €1.1m

Equity and liabilities
  • Profit (loss) carried forward +€637,051

    up €637,051 (+51.4%), from €1.2m to €1.9m

  • Advances received -€133,023

    down €133,023 (-75.2%), from €176,962 to €43,939

  • Trade debts +€78,599

    up €78,599 (+12.6%), from €621,349 to €699,949

    of which Bills of exchange payable: +€243,832

Income statement
  • Gross operating margin -€314,558

    down €314,558 (-22.9%), from €1.4m to €1.1m

  • Taxes -€54,452

    down €54,452 (-19.5%), from €279,101 to €224,649

  • Write-downs -€49,407

    down €49,407 (-86.6%), from €57,083 to €7,676

  • Depreciation -€38,421

    down €38,421 (-40.3%), from €95,399 to €56,977

  • Staff costs -€36,287

    down €36,287 (-36.5%), from €99,542 to €63,255

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €775,067
Gross operating margin -€314,558
Staff costs +€36,287
Depreciation +€38,421
Write-downs +€49,407
Other operating charges -€16,762
Other operating items -€1,245
Financial income +€21,456
Financial charges -€5,475
Taxes +€54,452
Result 2025 €637,051
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€170,774
Investment -€13,084
Financing -€31,875
Cash 2024 €1.0m
Net result for the year +€637,051
Depreciation +€56,977
Stocks and contracts -€96,846
Receivables within one year -€682,498
Deferred charges and accrued income +€282
Trade debts +€78,599
Tax, wage and social debts -€18,482
Advances received -€133,023
Other debts -€12,835
Investment in fixed assets (net) -€13,084
Short-term financial debts -€31,875
Cash 2025 €830,520
brings cash intakes cash out
Every line side by side 51 lines
Line Code 2024 2025 Change %
Total assets 20/58 €3,158,111 €3,677,546 +€519,435 +16.4%
Fixed assets 21/28 €109,453 €65,560 -€43,893 -40.1%
Intangible fixed assets 21 €91,461 €56,505 -€34,956 -38.2%
Tangible fixed assets 22/27 €17,386 €8,448 -€8,937 -51.4%
Plant, machinery and equipment 23 €5,650 €4,029 -€1,621 -28.7%
Furniture and vehicles 24 €11,736 €4,419 -€7,317 -62.3%
Financial fixed assets 28 €607 €607 = 0.0%
Current assets 29/58 €3,048,657 €3,611,986 +€563,329 +18.5%
Stocks and contracts in progress 3 €963,106 €1,059,952 +€96,846 +10.1%
Stocks 30/36 €963,106 €1,059,952 +€96,846 +10.1%
Amounts receivable within one year 40/41 €1,020,142 €1,702,640 +€682,498 +66.9%
Trade receivables 40 €983,801 €1,678,719 +€694,918 +70.6%
Other amounts receivable 41 €36,341 €23,920 -€12,420 -34.2%
Cash at bank and in hand 54/58 €1,046,252 €830,520 -€215,733 -20.6%
Deferred charges and accrued income 490/1 €19,157 €18,875 -€282 -1.5%
Total equity and liabilities 10/49 €3,158,111 €3,677,546 +€519,435 +16.4%
Equity 10/15 €1,814,880 €2,451,931 +€637,051 +35.1%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €556,090 €556,090 = 0.0%
Tax-exempt reserves 132 €42,100 €42,100 = 0.0%
Distributable reserves 133 €513,990 €513,990 = 0.0%
Profit (loss) carried forward 14 €1,240,190 €1,877,241 +€637,051 +51.4%
Amounts payable 17/49 €1,343,231 €1,225,615 -€117,616 -8.8%
Amounts payable within one year 42/48 €1,343,231 €1,225,615 -€117,616 -8.8%
Financial debts 43 €167,173 €135,298 -€31,875 -19.1%
Credit institutions 430/8 €167,173 €135,298 -€31,875 -19.1%
Trade debts 44 €621,349 €699,949 +€78,599 +12.6%
Suppliers 440/4 €621,349 €456,117 -€165,233 -26.6%
Bills of exchange payable 441 - €243,832 +€243,832
Advances received on contracts in progress 46 €176,962 €43,939 -€133,023 -75.2%
Taxes, remuneration and social security 45 €96,034 €77,551 -€18,482 -19.2%
Taxes 450/3 €80,036 €65,601 -€14,435 -18.0%
Remuneration and social security 454/9 €15,998 €11,950 -€4,048 -25.3%
Other amounts payable 47/48 €281,712 €268,878 -€12,835 -4.6%
Non-recurring operating income 76A €2,693 €5,457 +€2,764 +103%
Remuneration, social security and pensions 62 €99,542 €63,255 -€36,287 -36.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €95,399 €56,977 -€38,421 -40.3%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 €57,083 €7,676 -€49,407 -86.6%
Other operating charges 640/8 €8,018 €24,780 +€16,762 +209%
Non-recurring operating charges 66A €2,506 €3,751 +€1,245 +49.7%
Gross operating margin 9900 €1,374,885 €1,060,327 -€314,558 -22.9%
Operating profit (loss) 9901 €1,112,337 €903,888 -€208,449 -18.7%
Financial income 75/76B €16,267 €37,723 +€21,456 +132%
Recurring financial income 75 €16,267 €37,723 +€21,456 +132%
Financial charges 65/66B €74,437 €79,911 +€5,475 +7.4%
Recurring financial charges 65 €74,437 €79,911 +€5,475 +7.4%
Profit (loss) for the period before taxes 9903 €1,054,168 €861,700 -€192,468 -18.3%
Income taxes 67/77 €279,101 €224,649 -€54,452 -19.5%
Profit (loss) for the period 9904 €775,067 €637,051 -€138,016 -17.8%
Transfer from tax-exempt reserves 789 - €42,100 +€42,100
Profit (loss) for the period to be appropriated 9905 €775,067 €679,151 -€95,916 -12.4%

Value

latest balance sheet 31-05-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€3.2m to €4.0m

Midpoint €3.6m · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €2.4m
Capitalised earnings €4.0m to €5.6m
Indication €3.2m to €4.0m

Adjusted equity

balance sheet 31-05-2025
Equity (10/15)
€2,451,931
Intangible fixed assets (21)
-€56,505
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€2.4m

Capitalised earnings

net result for the year (9904)
2025
€637,051
excluding non-recurring income and charges
€635,345
2024
€775,067
excluding non-recurring income and charges
€774,880
2022
€277,376
excluding non-recurring income and charges
€283,975
2021
€259,593
2020
€232,574
Average result, excluding non-recurring income and charges
€564,733
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€4.0m / €4.7m / €5.6m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 May 2024 and 31 May 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 18 November 2026 via checked.be.